Tech Company Financing Transactions

Visiogen Funding Round

On 3/31/2005, Visiogen raised $8.3 million in funding from Prospect Venture Partners, Sprout Group and Three Arch Partners.

Transaction Overview

Company Name
Announced On
3/31/2005
Transaction Type
Venture Equity
Amount
$8,250,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
2 Goodyear B
Irvine, CA 92618
USA
Email Address
Overview
Visiogen, Inc. is focused on developing innovative products for cataract and refractive patients. Founded in Irvine, California, in 2001, Visiogen's first commercial application, Synchrony, a dual-optic intraocular lens and pre-loaded injector, is currently in clinical studies in the U.S. and recently received a CE Mark in Europe.
Profile
Visiogen LinkedIn Company Profile
Social Media
Visiogen Company Twitter Account
Company News
Visiogen News
Facebook
Visiogen on Facebook
YouTube
Visiogen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Reza Zadno
  Reza Zadno LinkedIn Profile  Reza Zadno Twitter Account  Reza Zadno News  Reza Zadno on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2005: Informative venture capital transaction
Next: 3/31/2005: Seahorse Bioscience venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary